SA PRO
Free Account
Integra LifeSciences Holdings CorporationIARTNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
22 analysts·High coverage
41%
Rating Distribution
Strong Buy
00%
Buy
941%
Hold
836%
Sell
523%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 35% higher.

Bear Case
$15.00
+35%
Consensus
$15.00
+35%
Bull Case
$15.00
+35%
Price Range22 analysts
Low
Consensus
High
$15.00
$15.00
Current Target
Current Price
$11.14
Upside to Target
$3.86

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 15, 2025Truist Financial
Integra LifeSciences price target raised to $15 from $13 at Truist
Target:$15.00
+1.7%from $14.76
Oct 7, 2024BTIG
BTIG Upgrades Integra LifeSciences (IART) to Neutral
Target:$20.00
+14.7%from $17.43
Jul 30, 2024Truist Financial
Integra LifeSciences price target lowered to $26 from $32 at Truist
Target:$26.00
+5.7%from $24.59
Jul 30, 2024Citigroup
Citi Downgrades Integra LifeSciences (IART) to Sell
Target:$23.00
-9.5%from $25.42
Jul 29, 2024BTIG
Integra LifeSciences downgraded to Sell from Neutral at BTIG
Target:$22.00
-13.5%from $25.42
Jul 16, 2024Truist Financial
Integra LifeSciences price target raised to $32 from $25 at Truist
Target:$32.00
+7.2%from $29.84
May 7, 2024Truist Financial
Integra LifeSciences (IART) PT Lowered to $25 at Truist Securities
Target:$25.00
+8.0%from $23.14
May 7, 2024JMP Securities
Integra LifeSciences price target lowered to $40 from $49 at JMP Securities
Target:$40.00
+72.9%from $23.14
May 6, 2024Wells Fargo
Wells Fargo Downgrades Integra LifeSciences (IART) to Equal Weight
Target:$25.00
+8.0%from $23.14
Oct 26, 2022Piper Sandler
Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem
Target:$50.00
+6.7%from $46.85
Jul 28, 2022Piper Sandler
Piper Sandler Cuts Price Target For Integra Lifesciences As It Divests Wound Care Portfolio
Target:$55.00
-2.7%from $56.53
May 20, 2021Jefferies
Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (NASDAQ: IART), Marinus (NASDAQ: MRNS) and ObsEva SA (NASDAQ: OBSV)
Target:$86.00
+21.2%from $70.95
Apr 29, 2021RBC Capital
Integra LifeSciences price target raised to $74 from $68 at Wells Fargo
Target:$74.00
-1.4%from $75.07
Apr 29, 2021Wells Fargo
Integra LifeSciences (IART) PT Raised to $74 at Wells Fargo
Target:$74.00
-1.4%from $75.07

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance